Insights into prion biology: Integrating a protein misfolding pathway with its cellular environment

Prion

Volumn 5, Issue 2, 2011, Pages 76-83

  DiSalvo, Susanne ^a   Serio, Tricia R ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Aggregate size; Amyloid; Chaperones; Hsp104; Ordered aggregates; Prion; Protein misfolding; Sup35; Transmission

Indexed keywords

AMYLOID; PRION PROTEIN;

AMINO ACID SEQUENCE; DEGENERATIVE DISEASE; NOTE; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN TRANSPORT;

AMYLOID; MODELS, BIOLOGICAL; PEPTIDE TERMINATION FACTORS; PRIONS; PROTEIN FOLDING; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; FUNGI;

EID: 79959385317     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.2.16413     Document Type: Note

References (140)

1. Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043-4.
2. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44. (Pubitemid 12089840)
3. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264:566-9.
4. Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823-33.
5. Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J 2005; 24:3082-92. (Pubitemid 41486344)
6. King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319-23. (Pubitemid 38418802)
7. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323-8. (Pubitemid 38418803)
8. +]. J Mol Biol 2007; 365:773-82. (Pubitemid 44960370)
9. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 2002; 99:7402-7. (Pubitemid 34568703)
10. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083-7.
11. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5.
12. Pezza JA, Serio TR. Prion Propagation: The Role of Protein Dynamics. Prion 2007; 1:36-43.
13. Sondheimer N, Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 2000; 5:163-72. (Pubitemid 30105445)
14. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-4. (Pubitemid 24263553)
15. +], a heritable prion-like factor of S cerevisiae. Cell 1997; 89:811-9.
16. King CY, Tittmann P, Gross H, Gebert R, Aebi M, Wuthrich K. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 1997; 94:6618-22. (Pubitemid 27281913)
17. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 1999; 283:1339-43.
18. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-3. (Pubitemid 32588105)
19. Dos Reis S, Coulary-Salin B, Forge V, Lascu I, Begueret J, Saupe SJ. The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils. J Biol Chem 2002; 277:5703-6. (Pubitemid 34968345)
20. Masel J, Jansen VA, Nowak MA. Quantifying the kinetic parameters of prion replication. Biophys Chem 1999; 77:139-52. (Pubitemid 29206647)
21. Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622-6. (Pubitemid 26262109)
22. Satpute-Krishnan P, Serio TR. Prion protein remodelling confers an immediate phenotypic switch. Nature 2005; 437:262-5. (Pubitemid 41294489)
23. Satpute-Krishnan P, Langseth SX, Serio TR. Hsp104-Dependent Remodeling of Prion Complexes Mediates Protein-Only Inheritance. PLoS Biol 2007; 5:24.
24. Derdowski A, Sindi SS, Klaips CL, DiSalvo S, Serio TR. A size threshold limits prion transmission and establishes phenotypic diversity. Science 2010; 330:680-3.
25. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859-68. (Pubitemid 24362673)
26. Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW Interactions among prions and prion "strains" in yeast. Proc Natl Acad Sci USA 2002; 99:16392-9.
27. Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375-86. (Pubitemid 26427888)
28. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65. (Pubitemid 28468829)
29. Schlumpberger M, Prusiner SB, Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 2001; 21:7035-46. (Pubitemid 32911263)
30. Wickner RB, Edskes HK, Shewmaker F, Kryndushkin D, Nemecek J. Prion variants, species barriers, generation and propagation. J Biol 2009; 8:47.
31. Dickinson AG, Meikle VM. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet 1971; 112:73-9.
32. Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329-34.
33. Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sine congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991; 72:595-603.
34. Pattison IH, Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Path 1961; 71:101-9.
35. Fraser H, Dickinson AG. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Path 1973; 83:29-40.
36. Carp RI, Callahan SM, Sersen EA, Moretz RC. Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination. Intervirology 1984; 21:61-9. (Pubitemid 14192036)
37. Dickinson AG, Taylor DM. Resistance of scrapie agent to decontamination. N Engl J Med 1978; 299:1413-4.
38. Kimberlin RH, Walker CA. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 1978; 39:487-96. (Pubitemid 8337652)
39. Kimberlin RH, Walker CA, Millson GC, Taylor DM, Robertson PA, Tomlinson AH, et al. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci 1983; 59:355-69. (Pubitemid 13094680)
40. Taylor DM, Fernie K, McConnell I, Steele PJ. Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies. Vet Microbiol 1998; 64:33-8. (Pubitemid 28556941)
41. Kimberlin RH, Cole S, Walker CA. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Biol 1987; 68:1875-81. (Pubitemid 17120438)
42. Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21:6358-66. (Pubitemid 35448414)
43. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 2004; 306:1793-6.
44. Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 1998; 273:32230-5. (Pubitemid 29177169)
45. Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural basis of yeast prion strain variants. Nature 2007; 449:233-7. (Pubitemid 47402368)
46. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 2002; 34:921-32. (Pubitemid 34722282)
47. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079-82. (Pubitemid 27020700)
48. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001; 10:854-63. (Pubitemid 32240511)
49. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585-9. (Pubitemid 44167919)
50. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995; 375:698-700.
51. Mulcahy ER, Bessen RA. Strain-specific kinetics of prion protein formation in vitro and in vivo. J Biol Chem 2004; 279:1643-9. (Pubitemid 38084430)
52. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 2006; 103:19105-10. (Pubitemid 350002835)
53. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337-48. (Pubitemid 28232079)
54. Sindi SS, Serio TR. Prion dynamics and the quest for the genetic determinant in protein-only inheritance. Curr Opin Microbiol 2009; 12:623-30.
55. +]: an epigenetic modulator of translation termination efficiency. Annu Rev Cell Dev Biol 1999; 15:661-703. (Pubitemid 32250389)
56. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, et al. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 1995; 14:4365-73.
57. Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, Kisselev L, et al. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 1995; 14:4065-72.
58. Cox B. [PSI], a cytoplasmic suppressor of supersuppression in yeast. Heredity 1965; 20:505-21.
59. +] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 1996; 15:3127-34. (Pubitemid 26187760)
60. +] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636-43.
61. Bagriantsev SN, Kushnirov VV, Liebman SW Analysis of amyloid aggregates using agarose gel electrophoresis. Meth Enz 2006; 412:33-48. (Pubitemid 44548572)
62. Byrne LJ, Cole DJ, Cox BS, Ridout MS, Morgan BJ, Tuite MF. The number and transmission of [PSI] prion seeds (Propagons) in the yeast Saccharomyces cerevisiae. PLoS ONE 2009; 4:4670.
63. +]. Genetics 2005; 169:1227-42. (Pubitemid 40547439)
64. +] prion in yeast. Curr Genet 1999; 35:59-67. (Pubitemid 29141247)
65. Crapeau M, Marchai C, Cullin C, Maillet L. The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion. Mol Biol Cell 2009; 20:2286-96.
66. Edskes HK, Gray VT, Wickner RB. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci USA 1999; 96:1498-503. (Pubitemid 29098479)
67. Baudin-Baillieu A, Fernandez-Bellot E, Reine F, Coissac E, Cullin C. Conservation of the prion properties of Ure2p through evolution. Mol Biol Cell 2003; 14:3449-58. (Pubitemid 37013140)
68. Kawai-Noma S, Pack CG, Tsuji T, Kinjo M, Taguchi H. Single mother-daughter pair analysis to clarify the diffusion properties of yeast prion Sup35 in guanidine-HCl-treated [PSI] cells. Genes Cells 2009 4:1045-54.
69. Haslberger T, Bukau B, Mogk A. Towards a unifying mechanism for ClpB/Hsp104-mediated protein disaggregation and prion propagation. Biochem Cell Biol 2010; 88:63-75.
70. Ness F, Ferreira P, Cox BS, Tuite MF. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 2002; 22:5593-605.
71. +] prion in yeast. Genetics 2003; 165:23-33. (Pubitemid 37204053)
72. +], a prion-like form of release factor eRF3. EMBO J 1999; 18:1182-91. (Pubitemid 29110303)
73. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61. (Pubitemid 41294488)
74. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Path 2010; 6:1000859.
75. Calvez V, Lenuzza N, Oelz D, Deslys JP, Laurent P, Mouthon F, et al. Size distribution dependence of prion aggregates infectivity. Math Biosci 2009; 217:88-99.
76. Zampieri M, Legname G, Altafini C. Investigating the conformational stability of prion strains through a kinetic replication model. PLoS Comput Biol 2009; 5:1000420.
77. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 2005; 102:2168-73. (Pubitemid 40262030)
78. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540-2.
79. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 1989; 59:847-57. (Pubitemid 20022375)
80. Wickner RB. Prion diseases: Infectivity versus toxicity. Nature 2011; 470:470-1.
81. Ghaemmaghami S, Phuan PW, Perkins B, Ullman J, May BC, Cohen FE, et al. Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci USA 2007; 104:17971-6. (Pubitemid 350210805)
82. Vishveshwara N, Bradley ME, Liebman SW. Sequestration of essential proteins causes prion associated toxicity in yeast. Mol Microbiol 2009; 73:1101-14.
83. Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992; 66:2096-101.
84. Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, Bartz JC. The Strain-Encoded Relationship between PrP Replication, Stability and Processing in Neurons is Predictive of the Incubation Period of Disease. PLoS Path 2011; 7:1001317.
85. Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC. Coinfecting prion strains compete for a limiting cellular resource. J Virol 2010; 84:5706-14.
86. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47. (Pubitemid 23201147)
87. Dickinson AG, Fraser H, Outram GW. Scrapie incubation time can exceed natural lifespan. Nature 1975 ; 256:732-3.
88. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75:10106-12. (Pubitemid 32948040)
89. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, et al. Search for a prion-specific nucleic acid. J Virol 2005; 79:10796-806.
90. Outram GW. The pathogenesis of scrapie in mice. In: Kimberlin RH, ed. Slow Virus Diseases of Animals and Man. Amsterdam: North-Holland 1976; 325-57.
91. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, et al. Prion clearance in bigenic mice. J Gen Virol 2005; 86:2913-23. (Pubitemid 41410483)
92. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302:871-4. (Pubitemid 37339628)
93. Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53:325-35. (Pubitemid 46161264)
94. Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, et al. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 2006; 116:3204-10. (Pubitemid 44878634)
95. White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci USA 2008; 105:10238-43.
96. Goldmann W, Chong A, Foster J, Hope J, Hunter N. The shortest known prion protein gene allele occurs in goats, has only three octapeptide repeats and is non-pathogenic. J Gen Virol 1998; 79:3173-6. (Pubitemid 29002358)
97. Dickinson AG, Stamp JT, Renwick CC, Rennie JC. Some factors controlling the incidence of scrapie in Cheviot sheep injected with a Cheviot-passaged scrapie agent. J Comp Path 1968; 78:313-21.
98. Hunter N, Moore L, Hosie BD, Dingwall WS, Greig A. Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland. Vet Rec 1997; 140:59-63. (Pubitemid 127777317)
99. Laplanche JL, Delasnerie-Laupretre N, Brandel JP, Chatelain J, Beaudry P, Alperovitch A, et al. Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies. Neurology 1994; 44:2347-51. (Pubitemid 24382735)
100. Belt PB, Muileman IH, Schreuder BE, Bos-de Ruijter J, Gielkens AL, Smits MA. Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol 1995; 76:509-17.
101. Maciulis A, Hunter N, Wang S, Goldmann W, Hope J, Foote WC. Polymorphisms of a scrapie-associated fibril protein (PrP) gene and their association with susceptibility to experimentally induced scrapie in Cheviot sheep in the United States. Am J Vet Res 1992; 53:1957-60.
102. Dickenson AG, Outram GW. Genetic aspects of unconventional virus infections: the basis fo the virino hypothesis. Ciba Foundation Symposium 1988; 135:63-83.
103. Bossers A, de Vries R, Smits MA. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 2000; 74:1407-14. (Pubitemid 30044090)
104. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:826-8. (Pubitemid 28280227)
105. Hizume M, Kobayashi A, Teruya K, Ohashi H, Ironside JW, Mohri S, et al. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. J Biol Chem 2009; 284:3603-9.
106. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767-78. (Pubitemid 26183813)
107. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224-33. (Pubitemid 29382879)
108. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383:685-90.
109. Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003; 126:1333-46.
110. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6. (Pubitemid 350098981)
111. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069-74.
112. Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, et al. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 2000; 74:4351-60. (Pubitemid 30214443)
113. Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, DeArmond SJ, et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci USA 2002; 99:13079-84.
114. Sc formation by lentiviral gene transfer of PrP containing dominant negative mutants. J Cell Sci 2004; 117:5591-7. (Pubitemid 40012205)
115. Furuya K, Kawahara N, Yamakawa Y, Kishida H, Hachiya NS, Nishijima M, et al. Intracerebroventricular delivery of dominant negative prion protein in a mouse model of iatrogenic Creutzfeldt-Jakob disease after dura graft transplantation. Neurosci Lett 2006; 402:222-6. (Pubitemid 43850152)
116. Toupet K, Compan V, Crozet C, Mourton-Gilles C, Mestre-Frances N, Ibos F, et al. Effective gene therapy in a mouse model of prion diseases. PLoS ONE 2008; 3:2773.
117. Atarashi R, Sim VL, Nishida N, Caughey B, Katamine S. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture. J Virol 2006; 80:7854-62. (Pubitemid 44182286)
118. Ott D, Taraborrelli C, Aguzzi A. Novel dominant-negative prion protein mutants identified from a randomized library. Protein Eng Des Sel 2008; 21:623-9.
119. Prusiner S, Scott M, Foster D, Pan K, Groth D, Mirenda C, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63:673-86. (Pubitemid 120035041)
120. Scott MR, Kohler R, Foster D, Prusiner SB. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1992; 1:986-97. (Pubitemid 23009207)
121. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 1993; 90:10608-12. (Pubitemid 23347091)
122. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83:79-90.
123. Telling GC, Scott M, Hsiao KK, Foster D, Yang SL, Torchia M, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 1994; 91:9936-40. (Pubitemid 24311923)
124. Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci USA 2003; 100:4784-9. (Pubitemid 36457806)
125. Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Path 2009; 5:1000535.
126. Lee CI, Yang Q, Perrier V, Baskakov IV. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci 2007; 16:2166-73. (Pubitemid 47481651)
127. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion and species barriers. Proc Natl Acad Sci USA 2000; 97:5836-41. (Pubitemid 30367485)
128. Priola SA. Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother 1999; 53:27-33. (Pubitemid 29167111)
129. Priola SA, Caughey B, Race RE, Chesebro B. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 1994; 68:4873-8.
130. Masel J, Jansen VA. Designing drugs to stop the formation of prion aggregates and other amyloids. Biophys Chem 2000; 88:47-59.
131. DePace AH, Santoso A, Hillner P, Weissman JS. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 1998; 93:1241-52. (Pubitemid 28307428)
132. Doel SM, McCready SJ, Nierras CR, Cox BS. The dominant PNM2-mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 1994; 137:659-70.
133. Young C, Cox B. Extrachromosomal Elements in A Super-Suppression System of Yeast I. A Nuclear Gene Controlling The Inheritance of the Extrachromosomal Elements. Heredity 1971; 26:413-22.
134. DiSalvo S, Derdowski A, Pezza JA, Serio TR. Dominant-Negative Prion Mutants Induce Curing Through Distinct Pathways That Promote Chaperone-Mediated Aggregate Disassembly. Nature Struct Mol Biol 2011; 18:486-92.
135. Bossers A, Belt P, Raymond GJ, Caughey B, de Vries R, Smits MA. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci USA 1997; 94:4931-6. (Pubitemid 27214713)
136. +] prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J 1998; 17:5805-10.
137. Osherovich LZ, Cox BS, Tuite MF, Weissman JS. Dissection and design of yeast prions. PLoS Biol 2004; 2:86.
138. Luheshi LM, Dobson CM. Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett 2009; 583:2581-6.
139. Bellotti V, Chiti F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol 2008; 18:771-9.
140. +]. Nat Struct Mol Biol 2011; 18:493-9.